Coala Life has developed a smartphone ECG device that can detect nine different arrhythmias for home-based monitoring.

The Swedish specialist in remote and real-time cardiac monitoring has expanded its capabilities to help monitor patients from home. The smartphone-powered ECG device automatically detects nine of the most common heart arrhythmias as well as normal sinus rhythm. This expansion is a result of the US FDA’s emergency guidance to help battle Covid-19.

“The ability with Coala to monitor patients remotely and obtain real-time ECG analysis of these most common arrhythmias offers progress in the care of patients who are at increased risk of various arrhythmias, some of which are life-threatening,” said Jerome Dwyer, cardiologist and electrophysiologist at the St Louis Cardiology Center. “Results are presented on the patient’s smartphone and to the connected healthcare provider in the Coala Care portal.”

The monitor is an FDA-cleared and CE class IIa medical device for remote cardiac monitoring using algorithms to detect arrhythmias such as atrial fibrillation. It has also recently been expanded to allow for remote respiratory monitoring with its integrated stethoscope.

Effective immediately, the monitor will also be able to detect and show ECG results for common arrhythmias such as AV Block II, tachycardia, multiple premature atrial contractions and multiple premature ventricular contractions.

The automatic ECG detection algorithms are available to support remote, real-time patient monitoring during the Covid-19 public health emergency, as per the FDA 2020-D-1138 guidance. These additional arrhythmias are available for the duration of the Covid-19 emergency.